# EDGAR Filing Document

**Accession Number:** 0000785161
**File Stem:** 0001127602-23-007406
**Filing Date:** 2023-2
**Character Count:** 9082
**Document Hash:** 3f6ea743193b8ac3599b9689634cad00
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-007406.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0001127602-23-007406

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230224

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230228

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Tarr Mark J
- **CENTRAL INDEX KEY:** 0001304057

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10315
- **FILM NUMBER:** 23680619

**MAIL ADDRESS:**
- **STREET 1:** C/O HEALTHSOUTH CORPORATION
- **STREET 2:** ONE HEALTHSOUTH PARKWAY
- **CITY:** BIRMINGHAM
- **STATE:** AL
- **ZIP:** 35243
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Encompass Health Corp
- **CENTRAL INDEX KEY:** 0000785161
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HOSPITALS [8060]
- **IRS NUMBER:** 630860407
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 9001 LIBERTY PARKWAY
- **CITY:** BIRMINGHAM
- **STATE:** AL
- **ZIP:** 35242
- **BUSINESS PHONE:** 205-967-7116

**MAIL ADDRESS:**
- **STREET 1:** 9001 LIBERTY PARKWAY
- **CITY:** BIRMINGHAM
- **STATE:** AL
- **ZIP:** 35242

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHSOUTH CORP
- **DATE OF NAME CHANGE:** 19950113

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHSOUTH REHABILITATION CORP
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

```

POWER OF ATTORNEY

	Know all men by these presents that the undersigned hereby
constitutes and appoints Patrick Darby and Stephen Leasure, and
each of them individually, the undersigned's true and lawful
attorney-in-fact to:

       (1) 	execute for and on behalf of the undersigned,
in the capacity as an officer and/or director of Encompass
Health Corporation, a Delaware corporation (the "Company"),
Forms 3, 4 and 5, Schedule 13D and Schedule 13G and amendments
thereto in accordance with Sections 13(d) and 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder, and any other forms or
reports the undersigned may be required to file in connection with the
undersigned's ownership, acquisition, or disposition of securities of
the Company;

       (2)	do and perform any and all acts for and on behalf
of the undersigned which may be necessary or desirable to complete
the execution of any such Form 3, 4 or 5, Schedule 13D, Schedule 13G,
or other form or report, and timely file such form, schedule or report
with the United States Securities and Exchange Commission and any other
authority; and

	(3)	take any other action of any type whatsoever in
connection with the foregoing which, in the opinion of each such
attorney-in-fact, may be of benefit to, in the best interest of,
or legally required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such
attorney-in-fact may approve in his or her discretion.

	The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform all and every act and thing
whatsoever requisite, necessary and proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents
and purposes as the undersigned might or could do if personally present,
with full power of substitution or revocation, and hereby ratifies and
confirms all that such attorney-in-fact, or his or her substitute or
substitutes, shall lawfully do or cause to be done by virtue of this
Power of Attorney and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorney-in-fact, in serving in such capacity
at the request of the undersigned, is not assuming any of the undersigned's
responsibilities to comply with Sections 13(d) and 16 of the Securities
Exchange Act of 1934.

	This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4, and 5,
Schedule 13D, Schedule 13G, or other form or report with respect to the
undersigned's holdings of and transactions in securities issued by the
Company, unless revoked by the undersigned in a signed writing delivered
to each foregoing attorney-in fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed effectively as of this 31st day of January 2023.

               /S/MARK J. TARR
Mark J. Tarr

{HS223737.1}

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Tarr Mark J<br><sub>(Last) (First) (Middle)</sub><br>2537 WATKINS ROAD<br><sub>(Street)</sub><br>MOUNTAIN BROOK, AL 35223<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-24 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President & CEO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Encompass Health Corp [ EHC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Encompass Health Common Stock | 2023-02-24 |  | F |  | 2256<sup>(1)</sup> | D | $60.22 | 500290 | D |  |
| Encompass Health Common Stock | 2023-02-27 |  | F |  | 2895<sup>(1)</sup> | D | $60.22 | 497395 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

**Signature:** /s/ Patrick Darby, attorney-in-fact for Mark J. Tarr  
**Date:** 2023-02-27

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**